skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 86,918  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Aged remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Intersection Between Aging and Cardiovascular Disease
Material Type:
Article
Add to My Research

The Intersection Between Aging and Cardiovascular Disease

Circulation research, 2012-04, Vol.110 (8), p.1097-1108 [Peer Reviewed Journal]

2012 American Heart Association, Inc. ;2015 INIST-CNRS ;2012 American Heart Association, Inc. 2012 ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.111.246876 ;PMID: 22499900 ;CODEN: CIRUAL

Full text available

2
The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels
Material Type:
Article
Add to My Research

The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels

Journal of the American College of Cardiology, 2017-04, Vol.69 (15), p.1952-1967 [Peer Reviewed Journal]

Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Apr 18, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.01.064 ;PMID: 28408026

Full text available

3
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
Material Type:
Article
Add to My Research

Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

The New England journal of medicine, 2019-01, Vol.380 (1), p.33-44 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1809944 ;PMID: 30415629

Full text available

4
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Material Type:
Article
Add to My Research

Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer

The New England journal of medicine, 2019-01, Vol.380 (1), p.23-32 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1811403 ;PMID: 30415637

Full text available

5
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Material Type:
Article
Add to My Research

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

The New England journal of medicine, 2017-08, Vol.377 (7), p.644-657 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1611925 ;PMID: 28605608

Full text available

6
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
Material Type:
Article
Add to My Research

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

The New England journal of medicine, 2017-10, Vol.377 (14), p.1319-1330 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1709118 ;PMID: 28844192

Full text available

7
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Material Type:
Article
Add to My Research

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

The New England journal of medicine, 2017-09, Vol.377 (13), p.1228-1239 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1612917 ;PMID: 28910237

Full text available

8
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly
Material Type:
Article
Add to My Research

Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

The New England journal of medicine, 2018-10, Vol.379 (16), p.1509-1518 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1805819 ;PMID: 30221597

Full text available

9
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
Material Type:
Article
Add to My Research

Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials

The Lancet (British edition), 2018-10, Vol.392 (10155), p.1311-1320 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31652-0 ;PMID: 30293769

Full text available

10
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control
Material Type:
Article
Add to My Research

Final Report of a Trial of Intensive versus Standard Blood-Pressure Control

The New England journal of medicine, 2021-05, Vol.384 (20), p.1921-1930 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1901281 ;PMID: 34010531

Full text available

11
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Material Type:
Article
Add to My Research

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

The New England journal of medicine, 2019-01, Vol.380 (4), p.347-357 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1812389 ;PMID: 30415602

Full text available

12
Sitting Time, Physical Activity, and Risk of Mortality in Adults
Material Type:
Article
Add to My Research

Sitting Time, Physical Activity, and Risk of Mortality in Adults

Journal of the American College of Cardiology, 2019-04, Vol.73 (16), p.2062-2072 [Peer Reviewed Journal]

2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019. The Authors ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.02.031 ;PMID: 31023430

Full text available

13
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Material Type:
Article
Add to My Research

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

The New England journal of medicine, 2015-11, Vol.373 (22), p.2117-2128 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1504720 ;PMID: 26378978

Full text available

14
Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
Material Type:
Article
Add to My Research

Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus

The New England journal of medicine, 2018-10, Vol.379 (16), p.1540-1550 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1804989 ;PMID: 30146932

Full text available

15
Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study
Material Type:
Article
Add to My Research

Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study

The Lancet (British edition), 2017-02, Vol.389 (10071), p.834-845 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 25, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31714-7 ;PMID: 28088338 ;CODEN: LANCAO

Full text available

16
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Material Type:
Article
Add to My Research

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

Diabetes care, 2018-02, Vol.41 (2), p.356-363 [Peer Reviewed Journal]

2017 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc17-1096 ;PMID: 29203583

Full text available

17
Clinical features and treatment of COVID-19 patients in northeast Chongqing
Material Type:
Article
Add to My Research

Clinical features and treatment of COVID-19 patients in northeast Chongqing

Journal of Medical Virology, 2020-07, Vol.92 (7), p.797 [Peer Reviewed Journal]

2020 Wiley Periodicals, Inc. ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;EISSN: 1096-9071 ;DOI: 10.1002/jmv.25783 ;PMID: 32198776

Digital Resources/Online E-Resources

18
24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk
Material Type:
Article
Add to My Research

24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk

The New England journal of medicine, 2022-01, Vol.386 (3), p.252-263 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2109794 ;PMID: 34767706

Full text available

19
CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries
Material Type:
Article
Add to My Research

CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries

Cardiovascular diabetology, 2021-07, Vol.20 (1), p.154-154, Article 154 [Peer Reviewed Journal]

2021. The Author(s). ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2021 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-021-01344-0 ;PMID: 34315481

Full text available

20
Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate
Material Type:
Article
Add to My Research

Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate

Kidney international, 2018-06, Vol.93 (6), p.1442-1451 [Peer Reviewed Journal]

2018 International Society of Nephrology ;Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 2018 ;ISSN: 0085-2538 ;ISSN: 1523-1755 ;EISSN: 1523-1755 ;DOI: 10.1016/j.kint.2018.01.009 ;PMID: 29605094

Full text available

Results 1 - 20 of 86,918  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1964  (105)
  2. 1964 To 1978  (1,768)
  3. 1979 To 1993  (4,105)
  4. 1994 To 2009  (25,064)
  5. After 2009  (55,924)
  6. More options open sub menu

Language 

  1. English  (82,481)
  2. Japanese  (11,902)
  3. German  (892)
  4. Spanish  (866)
  5. French  (772)
  6. Russian  (640)
  7. Portuguese  (581)
  8. Italian  (362)
  9. Chinese  (248)
  10. Polish  (212)
  11. Norwegian  (130)
  12. Swedish  (85)
  13. Turkish  (67)
  14. Dutch  (64)
  15. Czech  (63)
  16. Hungarian  (54)
  17. Romanian  (47)
  18. Danish  (44)
  19. Korean  (26)
  20. Croatian  (23)
  21. More options open sub menu

Searching Remote Databases, Please Wait